DiaMedica Therapeutics (DMAC) Institutional Ownership $3.82 -0.32 (-7.73%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$3.82 +0.01 (+0.13%) As of 03/28/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for DiaMedica Therapeutics (NASDAQ:DMAC)CurrentInstitutional OwnershipPercentage10.12%Number ofInstitutional Buyers(last 12 months)22TotalInstitutional Inflows(last 12 months)$5.53MNumber ofInstitutional Sellers(last 12 months)0 Get DMAC Insider Trade Alerts Want to know when executives and insiders are buying or selling DiaMedica Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DMAC Institutional Buying and Selling by Quarter Remove Ads DiaMedica Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 OMERS ADMINISTRATION Corp22,500$122K0.0%N/A0.053% 2/17/2025 Millennium Management LLC84,829$461K0.0%+151.8%0.198% 2/17/2025 Balyasny Asset Management L.P.14,581$79K0.0%N/A0.034% 2/17/2025 683 Capital Management LLC76,116$413K0.0%N/A0.178% 2/14/2025 Jane Street Group LLC42,212$229K0.0%N/A0.099% 2/14/2025 Schonfeld Strategic Advisors LLC26,097$142K0.0%N/A0.061% 2/14/2025 Northern Trust Corp180,192$978K0.0%+49.8%0.421% 2/14/2025 Susquehanna International Group LLP374,845$2.04M0.0%+269.5%0.877% 2/14/2025 Dimensional Fund Advisors LP19,339$105K0.0%+14.0%0.045% 2/13/2025 Barclays PLC27,726$151K0.0%N/A0.065% Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/13/2025 Raymond James Financial Inc.15,267$83K0.0%N/A0.036% 2/13/2025 Bank of Montreal Can15,560$84K0.0%N/A0.036% 2/12/2025 World Investment Advisors21,915$119K0.0%N/A0.051% 2/12/2025 Paragon Associates & Paragon Associates II Joint Venture514,784$2.80M6.5%+6.7%1.204% 2/11/2025 LPL Financial LLC152,000$825K0.0%+8.2%0.355% 2/6/2025 Raymond James Financial Inc.15,267$83K0.0%N/A0.036% 2/6/2025 Meridian Wealth Management LLC27,216$148K0.0%N/A0.064% 2/4/2025 Y Intercept Hong Kong Ltd14,973$81K0.0%N/A0.035% 1/30/2025 Blue Trust Inc.69,122$375K0.0%+56.2%0.162% 1/22/2025 Blue Trust Inc.69,122$375K0.0%+56.2%0.162% 11/16/2024 Geode Capital Management LLC306,958$1.29M0.0%+29.6%0.718% 11/15/2024 Point72 Asia Singapore Pte. Ltd.9,498$40K0.0%N/A0.022% 10/18/2024 Blue Trust Inc.44,247$185K0.0%N/A0.104% 8/16/2024 Magnolia Capital Advisors LLC29,500$87K0.0%N/A0.069% 5/10/2024 Vanguard Group Inc.1,013,522$2.81M0.0%+26.3%2.670% 2/15/2024 Paragon Associates & Paragon Associates II Joint Venture500,000$1.42M3.3%+6.4%1.318% 2/7/2024 Avantax Advisory Services Inc.12,500$36K0.0%N/A0.033% 11/15/2023 Stonebridge Capital Advisors LLC20,000$52K0.0%N/A0.053% 11/13/2023 EAM Investors LLC212,512$548K0.1%-21.4%0.560% 11/9/2023 Bleichroeder LP222,317$574K0.1%-24.4%0.586% 11/1/2023Jacob Asset Management of New York LLC168,730$435K0.6%-15.1%0.445% 8/30/2023 Cooperman Leon G875,993$3.78M0.2%+0.9%2.308% 8/10/2023Jacob Asset Management of New York LLC198,730$859K1.0%-15.0%0.738% 8/2/2023 Catalyst Financial Partners LLC36,267$157K0.1%+44.4%0.135% 4/11/2023 Catalyst Financial Partners LLC25,110$38K0.0%+73.5%0.095% 5/12/2022Jacob Asset Management of New York LLC265,000$663K0.4%-3.6%1.002% 2/15/2022 Stonepine Capital Management LLC1,194,670$4.46M2.0%+620.7%4.519% 11/15/2021 Marshall Wace LLP10,031$40K0.0%-93.6%0.053% 11/15/2021 Manatuck Hill Partners LLC273,100$1.10M0.4%-52.1%1.454% 11/12/2021 Stonepine Capital Management LLC165,775$665K0.3%-60.5%0.882% Trump’s betrayal exposed (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma11/12/2021 Jump Financial LLC18,300$73K0.0%N/A0.097% 11/9/2021BlackRock Inc.55,970$225K0.0%-8.6%0.298% 8/25/2021 Marshall Wace LLP155,662$693K0.0%+104.9%0.829% 8/16/2021 State Street Corp30,217$134K0.0%N/A0.161% 8/16/2021Corriente Advisors LLC203,641$906K0.5%-76.6%1.084% 8/16/2021 Marshall Wace LLP155,662$693K0.0%+104.9%0.829% 8/13/2021 Renaissance Technologies LLC94,100$419K0.0%-38.5%0.501% 8/13/2021 Geode Capital Management LLC133,569$594K0.0%+4.0%0.711% 8/13/2021 Vanguard Group Inc.786,266$3.50M0.0%-7.1%4.185% 8/12/2021 Trexquant Investment LP17,019$76K0.0%N/A0.091% 8/12/2021 Dimensional Fund Advisors LP14,074$63K0.0%N/A0.075% 8/12/2021 JPMorgan Chase & Co.8,299$37K0.0%N/A0.044% 8/12/2021 Bank of Montreal Can142,846$694K0.0%+36.7%0.760% 5/21/2021 Citadel Advisors LLC20,601$189K0.0%N/A0.110% 5/19/2021 Squarepoint Ops LLC35,536$325K0.0%N/A0.189% 5/18/2021 Millennium Management LLC70,281$643K0.0%+72.0%0.374% 5/18/2021 Point72 Asset Management L.P.552,250$5.05M0.0%-31.0%2.940% 5/18/2021Corriente Advisors LLC870,228$7.96M2.9%+7.8%4.632% 5/18/2021 Citadel Advisors LLC20,601$189K0.0%N/A0.110% 5/13/2021 Barclays PLC3,412$31K0.0%N/A0.018% 5/13/2021 Renaissance Technologies LLC153,100$1.40M0.0%+35.0%0.815% 5/13/2021 Bank of New York Mellon Corp40,576$371K0.0%-5.4%0.216% 5/13/2021 Bank of Montreal Can104,524$982K0.0%+27.7%0.556% 5/12/2021 Northern Trust Corp85,026$778K0.0%-29.7%0.453% 5/12/2021 Geode Capital Management LLC128,468$1.18M0.0%+23.9%0.684% 5/12/2021Granite Point Capital Management L.P.184,380$1.69M0.1%-66.3%0.981% 5/11/2021 EAM Investors LLC108,232$990K0.1%-1.6%0.576% 5/7/2021BlackRock Inc.60,165$551K0.0%+7.9%0.320% 4/27/2021 Dorsey Wright & Associates3,937$36K0.4%N/A0.021% 2/24/2021 Virtu Financial LLC15,712$159K0.0%N/A0.084% 2/17/2021 Jane Street Group LLC12,537$127K0.0%N/A0.067% 2/16/2021 ExodusPoint Capital Management LP13,160$133K0.0%N/A0.070% 2/11/2021 Northern Trust Corp120,989$1.23M0.0%+3.6%0.646% 2/10/2021 Renaissance Technologies LLC113,400$1.15M0.0%+18.1%0.605% 2/9/2021 Bank of New York Mellon Corp42,905$435K0.0%+218.5%0.229% 2/5/2021BlackRock Inc.55,781$566K0.0%+27.4%0.298% (Data available from 1/1/2016 forward)Remove Ads DMAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DMAC shares? During the previous two years, 29 institutional investors and hedge funds held shares of DiaMedica Therapeutics. The most heavily invested institutionals were Cooperman Leon G ($3.78M), Vanguard Group Inc. ($2.81M), Paragon Associates & Paragon Associates II Joint Venture ($2.80M), Susquehanna International Group LLP ($2.04M), Geode Capital Management LLC ($1.29M), Northern Trust Corp ($978K), and LPL Financial LLC ($825K).Learn more on DMAC's institutional investors. What percentage of DiaMedica Therapeutics stock is owned by institutional investors? 10.12% of DiaMedica Therapeutics stock is owned by institutional investors. Learn more on DMAC's institutional investor holdings. Which institutional investors have been buying DiaMedica Therapeutics stock? Of the 26 institutional investors that purchased DiaMedica Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Susquehanna International Group LLP ($273.40K), Vanguard Group Inc. ($211.35K), Blue Trust Inc. ($94.00K), 683 Capital Management LLC ($76.12K), Geode Capital Management LLC ($70.07K), Paragon Associates & Paragon Associates II Joint Venture ($62.17K), and Northern Trust Corp ($59.90K). How much institutional buying is happening at DiaMedica Therapeutics? Institutional investors have bought a total of 1,256,204 shares in the last 24 months. This purchase volume represents approximately $5.82M in transactions. Which DiaMedica Therapeutics major shareholders have been selling company stock? The following institutional investors have sold DiaMedica Therapeutics stock in the last 24 months: Bleichroeder LP ($71.80K), Jacob Asset Management of New York LLC ($65K), and EAM Investors LLC ($57.91K). How much institutional selling is happening at DiaMedica Therapeutics? Institutional investors have sold a total of 194,707 shares in the last 24 months. This volume of shares sold represents approximately $563.24K in transactions. Related Companies Intellia Therapeutics Major Shareholders Enliven Therapeutics Major Shareholders Arcus Biosciences Major Shareholders Vir Biotechnology Major Shareholders Collegium Pharmaceutical Major Shareholders Rocket Pharmaceuticals Major Shareholders Xencor Major Shareholders Replimune Group Major Shareholders Phibro Animal Health Major Shareholders Zymeworks Major Shareholders This page (NASDAQ:DMAC) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DMAC Stock Free DMAC Stock Alerts